Memry Corporation FY 2007 Revenues $51.7M; Net Income $317,000 or $0.01...(Intangible assets net ...),Health
Navigation Links
Memry Corporation FY 2007 Revenues $51.7M; Net Income $317,000 or $0.01 Per Share
Date:9/17/2007
Intangible assets, net 6,500,000 7,171,000
Goodwill 14,146,000 14,146,000
Deferred financing costs, net 89,000 355,000
Deferred tax assets 1,769,000 1,821,000
Investment 409,000 409,000
Deposits and other assets 155,000 159,000
Total other assets 23,068,000 24,061,000
TOTAL ASSETS $48,746,000 $55,300,000
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued expenses $5,606,000 $5,478,000
Notes payable 970,000 2,173,000
Income tax payable 50,000 215,000
Total current liabilities 6,626,000 7,866,000
Notes payable, less current maturities 645,000 7,818,000
Other non-current liabilities 125,000 116,000
Stockholders' equity
Common stock, $0.01 par value, 60,000,000
shares authorized; 29,851,870 and 29,077,486
shares issued and outstanding at June 30,
2007 and 2006, respectively 299,000 291,000
Additional paid-in capital 56,471,000 54,946,000
Accumulated deficit (15,420,000) (15,737,000)
Total stockholders' equity 41,350,000 39,500,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $48,746,000 $55,300,000
Investor Relation Information:
Hawk Associates, Inc.
Frank N. Hawkins, Jr. or Julie Marshall
Phone: (305) 451-1888
E-mail: info@hawkassociates.com
'/>"/>
| SOURCE Memry Corporation Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
2. Shorter infants have lower incomes in later life
3. Research shows that death may occur differently depending on the income level
4. Education And Income Level May Not Guarantee Health
5. The trident of unhealthy teen choices is early Lunch, Soft Drink Machine Income and Parents who relent
6. Health Insurance for Low-Income Expats in UAE
7. Classes on Proper Use of Diet Supplements for Low Income Group Elders
8. Spouses Income Taken Into Account In Nursing Home Charges
9. The higher the income the lower the disability rates!
10. Kids From Low-Income Groups Could Enhance Their Nutrition By Choosing Better After School Snacks
11. Social Drinking Increases Income
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 2Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 3Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2
[0] Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance [0] New Blood Thinner Could Replace Warfarin to Fight Venous Clots[0] New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V)[0] Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists[0] Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference
Other Medicine News:Health News:IPC The Hospitalist Company, Inc. Files Registration Statement for Proposed Offering 2Health News:IPC The Hospitalist Company, Inc. Files Registration Statement for Proposed Offering 3Health News:Potential new role for red grape seeds in treatment of Alzheimer's disease 2Health News:Lifestyle Changes Affect Cancer Genes 2Health News:Lifestyle Changes Affect Cancer Genes 3Health News:Home Care Workers, Seniors, Disabled From Across Massachusetts to Protest Poverty Wages, Lack of Health Insurance, Wednesday, June 18 at Office of Governor Deval Patrick 2Health News:Home Care Workers, Seniors, Disabled From Across Massachusetts to Protest Poverty Wages, Lack of Health Insurance, Wednesday, June 18 at Office of Governor Deval Patrick 3Health News:Johnson & Johnson and American Red Cross Announce Resolution of Lawsuit 2Health News:Diabetes and Depression Go Hand-in-Hand 2Health News:Diabetes and Depression Go Hand-in-Hand 3
IPC The Hospitalist Company, Inc. Files Registration Statement for Proposed OfferingPotential new role for red grape seeds in treatment of Alzheimer's diseaseLifestyle Changes Affect Cancer GenesHome Care Workers, Seniors, Disabled From Across Massachusetts to Protest Poverty Wages, Lack of Health Insurance, Wednesday, June 18 at Office of Governor Deval PatrickJohnson & Johnson and American Red Cross Announce Resolution of LawsuitDiabetes and Depression Go Hand-in-Hand
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Amber Pharmacy Earns Accreditation From ACHC 2Houston Northwest Medical Centers Bariatric Program Rated Top 15 25 in the Nation by HealthGrades 52902 1Houston Northwest Medical Centers Bariatric Program Rated Top 15 25 in the Nation by HealthGrades 52902 2Houston Northwest Medical Centers Bariatric Program Rated Top 15 25 in the Nation by HealthGrades 52902 3Cynosure Reports Second Quarter 2009 Financial Results 13226 1Cynosure Reports Second Quarter 2009 Financial Results 13226 2Cynosure Reports Second Quarter 2009 Financial Results 13226 3Cynosure Reports Second Quarter 2009 Financial Results 13226 4Cynosure Reports Second Quarter 2009 Financial Results 13226 5Cynosure Reports Second Quarter 2009 Financial Results 13226 6Cynosure Reports Second Quarter 2009 Financial Results 13226 7Cynosure Reports Second Quarter 2009 Financial Results 13226 8Cynosure Reports Second Quarter 2009 Financial Results 13226 9Cynosure Reports Second Quarter 2009 Financial Results 13226 10Cynosure Reports Second Quarter 2009 Financial Results 13226 11Cynosure Reports Second Quarter 2009 Financial Results 13226 12Cynosure Reports Second Quarter 2009 Financial Results 13226 13QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 1QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 2QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 3QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 4QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 5QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 6QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System 52896 7
Other Medicine Technology:Agendia's MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines 2Agendia's MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines 3Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 2Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 3Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 4Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 5Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 6Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 7Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 8
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |